Logo
Apparel & Fashion

Description

Maxipime injection represents a fourth-generation cephalosporin antibiotic designed for serious bacterial infections requiring hospital-based care. This pharmaceutical formulation contains cefepime hydrochloride as its active ingredient, providing broad-spectrum activity against both gram-positive and gram-negative bacteria. The injection form ensures rapid bioavailability and immediate therapeutic action, making it indispensable in critical care scenarios where timing directly impacts patient outcomes. Medical professionals trust Maxipime for its consistent potency and reliable performance in challenging clinical situations where effective antibiotic coverage is crucial for patient recovery.

Healthcare institutions across multiple specialties utilize Maxipime injection for its comprehensive antibacterial coverage. Hospitals deploy this antibiotic in intensive care units for ventilator-associated pneumonia, surgical departments for post-operative infections, and oncology wards for feb...
Maxipime injection represents a fourth-generation cephalosporin antibiotic designed for serious bacterial infections requiring hospital-based care. This pharmaceutical formulation contains cefepime hydrochloride as its active ingredient, providing broad-spectrum activity against both gram-positive and gram-negative bacteria. The injection form ensures rapid bioavailability and immediate therapeutic action, making it indispensable in critical care scenarios where timing directly impacts patient outcomes. Medical professionals trust Maxipime for its consistent potency and reliable performance in challenging clinical situations where effective antibiotic coverage is crucial for patient recovery.

Healthcare institutions across multiple specialties utilize Maxipime injection for its comprehensive antibacterial coverage. Hospitals deploy this antibiotic in intensive care units for ventilator-associated pneumonia, surgical departments for post-operative infections, and oncology wards for febrile neutropenia cases. Emergency departments stock Maxipime for severe community-acquired infections requiring immediate intervention. The product meets the stringent requirements of modern healthcare facilities that demand antibiotics with proven efficacy against multidrug-resistant organisms and complex infection sites, ensuring consistent treatment protocols across various medical departments.

Maxipime delivers exceptional business value through its proven reliability and consistent clinical performance. Healthcare procurement managers prioritize this antibiotic for its predictable results, reduced treatment failure rates, and overall cost-effectiveness in managing serious infections. The product's manufacturing follows strict quality control standards ensuring every vial meets pharmaceutical specifications. Distributors and wholesalers benefit from established demand patterns and consistent reorder cycles from medical facilities that incorporate Maxipime into their standard treatment protocols, creating stable supply chain relationships and predictable inventory management.

Key Features:
- Fourth-generation cephalosporin antibiotic with cefepime hydrochloride
- Broad-spectrum coverage against gram-positive and gram-negative bacteria
- Intravenous administration for immediate therapeutic effect
- Manufactured under strict pharmaceutical quality control standards
- Consistent potency and reliable performance in clinical settings

Benefits:
- Effective treatment for serious bacterial infections in hospital settings
- Rapid action through intravenous administration for critical cases
- Proven reliability against multidrug-resistant pathogens
- Consistent quality ensuring predictable treatment outcomes
- Trusted by medical professionals across various healthcare specialties

Specifications

Additional Information
Country of OriginIndia

Application

Maxipime injection is specifically formulated for healthcare settings requiring potent antibacterial treatment. It is administered intravenously by medical professionals to ensure precise dosage and optimal patient outcomes in controlled clinical environments. This antibiotic is essential in modern medical practice where bacterial infections pose significant risks to patient health and recovery timelines. This pharmaceutical product serves critical roles across multiple medical departments including intensive care units, surgical wards, and emergency medicine. Hospitals, clinics, and healthcare networks rely on Maxipime for its consistent quality and proven efficacy in combating complex bacterial infections that require immediate and powerful antibiotic intervention. - Hospital-acquired pneumonia treatment in intensive care units - Complicated urinary tract infections in hospitalized patients - Severe skin and soft tissue infections requiring intravenous antibiotics - Febrile neutropenia management in immunocompromised patients - Intra-abdominal infections following surgical procedures

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Aark Pharmaceuticals
Aark Pharmaceuticals, New Delhi
TruBasic
IndiaNew Delhi, India
Trading Company•Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Hospital Antibiotic Maxipime Injection For Bacterial Infections

Hospital Antibiotic Maxipime Injection treats serious bacterial infections with broad-spectrum coverage. This reliable cephalosporin antibiotic is essential for healthcare facilities managing complex infections requiring intravenous administration.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Aark Pharmaceuticals
TruBasic
IndiaNew Delhi, India
Trading Company

More Products From Supplier